Source: Medical Device Network Hearing Aid,Hearing Assist,Hearing Aid Devices,In Ear Hearing Aids Shenzhen Sunshine Technology Co.,Ltd , https://www.szyatwin.com
China DR Industry (2016-2017) Report
:2017-02-22
After more than ten years of development, China's DR industry has gradually matured. With the global economic recovery and the sustained rapid development of China's economy, the medical industry has entered an unprecedented period of development opportunities. The DR industry has erupted, making great progress in technology research, product development, sales growth, and clinical applications.
In recent years, DR technology breakthroughs, mainly focused on "precise imaging", the core achievement is the research and popularization of "dynamic imaging technology". Dynamic imaging technology, because it has changed the past blind imaging technology, the combination of perspective and high-definition capture imaging technology, thus achieving the historical revolution of precision imaging. This technology has become the most stable and cutting-edge clinical application technology in the DR industry.
In terms of products, the development of traditional static DR products mainly focuses on the changes of mechanical structure, as well as the composite superposition of mature applications such as dual-energy subtraction and three-dimensional imaging. The fastest product development is dynamic DR products. In addition to the upgrade of static DR technology to dynamic DR, dynamic DR has made more breakthroughs in mechanical structure, product function, and human body mechanics applications.
In terms of sales volume, the absolute sales volume of the entire DR industry is currently growing at 20%. In 2016, the national total sales volume was around 15,000 units, but the growth rate of static DR has dropped from 20% in 2015 to the current 18%. CR, vintage X-ray The machine relies on the long tail market and has a certain market share, but it has already experienced negative growth. The main force to ensure overall sales growth has now become a dynamic DR. From the industry point of view, the sales of dynamic DR products of major dynamic DR manufacturers including Anjian Technology, Wandong Medical and Kangda International have doubled. And the proportion of dynamic DR sales within these companies has expanded rapidly year by year.
Clinically, with the development and popularization of precision imaging technology, clinical applications are also moving toward the direction of dynamic DR. At present, clinical applications such as instantaneous high-definition spotting under visual conditions have been written into some undergraduate and postgraduate textbooks in China.
In terms of the development of China's DR enterprises in the context of globalization, since most of China's DR manufacturers are positioned to “serve services based on the Chinese marketâ€, they have not gained much in the face of this big cake in the international market. A small number of 1-2 companies based on products in the global market are currently developing strongly. For example, the dynamic DR technology leader An Jian Technology, through the dynamic DR products, has caused great repercussions in the international market.
Overall, the DR industry is developing very well, but the various technologies and products are upgrading with the industry.
Second, the market size and growth rate
As of the end of June 2016, the number of medical and health institutions nationwide reached 989,000, including 28,000 hospitals , 927,000 primary health care institutions, 31,000 professional public health institutions, and 33,000 other institutions. Compared with the end of June 2015, there were 3,160 medical and health institutions nationwide, including 1,804 hospitals and 5,698 primary health care institutions. This is the basis for the size of the entire market. It is precisely because of the huge potential of the Chinese medical market and the rapid growth, which has led to the rapid development of the DR industry.
Since 2012, China's DR industry has started to develop at a high speed. The 2012-2016 China DR sales statistics are as follows:
From a global perspective, the Chinese market is dominated. In 2015, the DR market share of the entire Asia-Pacific region accounted for 20.5% of the global market; China accounted for about 70% of the Asia-Pacific region; that is, China’s DR share accounted for 14.35% of the world, which accounted for 2016. The change is not big.
Compared with the US market with relatively abundant medical resources development, the ratio of China to the US population is 4.26:1; the ratio of US to China market share is 3.22:1; that is, the US and US per capita DR market share is 13.72 times that of China.
From the comparative analysis of China and the United States, it can be seen that there is a huge gap in the maturity of the DR market between China and the United States. In the Chinese market, there are objective reasons such as regional imbalances, but the DR industry is still developing strongly, maintaining an average annual growth rate of 20%. With the development of the two-child policy, aging trend, grading diagnosis and treatment reform, and private capital drive, it is expected that the annual growth rate of the DR industry will remain at around 20% in the next five years.
　　 China's DR sales forecast for 2017-2021 is as follows:
Third, the driving force of industry development
The DR industry maintains rapid growth and has a variety of internal and external factors. Internally, it mainly includes technological innovation, product upgrades, model iterations, etc.; from the external environment, including policy influences, user habits, and global economic cycles.
From the perspective of key factors, the first is technical innovation. From the perspective of the global DR industry, dynamic imaging technology has become the most advanced technology in the application field, but the development of laboratory technology is changing with each passing day, such as: zoom point 3D technology, multi-layer super flat panel detector technology, three-dimensional energy spectrum Y Arm technology, rotational scanning energy spectrum detector technology, backscatter imaging technology, single photon detector technology, dynamic compression sensing technology, etc. Among them, the research in the field of energy spectrum imaging is relatively intensive, and it is the new growth point of the DR industry in the next five years. As technology advances, products will grow at a faster rate.
In addition, the rise of domestically produced equipment and accelerated import substitution have also given China's DR industry a stronger driving force for development. The depreciation of the renminbi has also provided good opportunities for Chinese companies to go global.
In general, the DR industry has strong development momentum and there is a lot of room for growth in the future.
Fourth, the market competition pattern
At present, although the market capacity of the DR industry is increasing rapidly year by year, from the perspective of the competitive landscape within the industry, the low-end market has entered a bleak situation of vicious competition, while the mid-to-high-end market is a blank area. In other words, most of the capacity of Chinese DR companies is concentrated in the low-end market, and this area is an area with many enterprises, mixed products and chaotic prices.
From the sales structure in 2016, the low-end market sales accounted for nearly one-third of total sales, reaching 5,500-6,000 units. Most of the sales of Chinese DR companies are concentrated in this area.
At present, the major manufacturers in China's DR industry (more than 500 sales) include: Anjian Technology, Wandong Medical, Kangda International, Shanghai Lian Ying, Shenzhen Mindray. With the development of dynamic DR, enterprises that have transformed into dynamic DR will develop rapidly in the next five years, including: Anjian Technology, Zhuhai Pride, Wandong Medical, Kangda International, Guangzhou Xianhao and other enterprises.
Among them, in 2016, the overall sales of various manufacturers are as follows:
With the rise of dynamic DR, in the next five years (assuming no new technology breakthroughs), more than half of the low-end market will be occupied by dynamic DR, while most of the mid- to high-end market will be occupied by dynamic DR. It can be expected that in 2021, the dynamic DR market will reach more than 75% of the overall DR market.
V. Analysis of representative enterprises
In the five-year development of 2012-2016, the innovation of the DR industry is huge. Representative enterprises include the inventor of dynamic DR technology, An Jian Technology, the fast-rising red power Shanghai Lian Ying, the transformation and upgrading of the old-fashioned powerhouse Wandong Medical, and the low end. The market's new Perth creatures and so on.
Anjian Technology: This is a company that relies on independent research and development as the foundation of enterprise survival. It has created the first independent research and development static DR, the first independent research and development dynamic detector, the first independent research and development dynamic DR, etc. First. For the fourth consecutive year, it has won the China DR sales champion. In the past, it has received little attention and has been rated as “invisible champion†in the industry. At present, Anjian Technology has become the main force in the development of China's DR technology. Its performance in the international market is also very eye-catching. With the launch of dynamic DR products, it has formed a strong development momentum in many regions such as Southeast Asia.
Shanghai Lian Ying: This is a red force with the core purpose of “import substitutionâ€. In China, the confrontation between Lian Ying and GPS has been gradually upgraded. Its self-developed MRI, CT and other high-end products have gradually been recognized by the domestic market, and its DR development is also very rapid. In just a few years, it has achieved annual sales breakthrough. 700 units. In the face of the Chinese market, there will be more possibilities with the help of red power. This is a model of combining high technology with strong relationships.
Wandong Medical: This is a 62-year-old company. After several twists and turns, it falls into private capital, and it has a good destination. Although it experienced short-term personnel adjustments and market volatility, its brand penetration has been high, its penetration rate in the Chinese market is high, and its sales growth has gradually picked up. At present, it is the technical reserve that restricts its development, because the many changes of Wandong Medical in recent years have coincided with the critical period of the development of dynamic DR technology, and missed development opportunities. Despite this, there is still great potential for development based on the Chinese market.
Perth Bio: This is a cutting-edge company that is currently eye-catching in the market. In just a few years, sales have approached 300 units, making it a strong company. At present, the effect of the company's low-price penetration strategy is obvious. Of course, this development model is also in great danger. If there is no new technology reserve, market penetration will become the cause of corporate decline. Long-term low-margin development will have many disadvantages for brand building. Perth Bio is a representative of companies that employ a number of low-cost competitive strategies.
In addition, there are more than 140 DR companies, most of which are based on the Chinese market, using core components for outsourcing, self-assembly and sales, implementing low-cost and fast-selling marketing methods, and barbaric growth. Similar to dealers, the industry regards such companies as “source distributorsâ€.
In general, among the Chinese DR companies, the enterprises that really focus on technology research and development have already collapsed, and the sales volume of the industry is also rapidly moving closer to the front. The industry's Matthew effect is obvious and the reshuffle is intensified. This is fatal for some companies and necessary adjustments for industry development.
Six, the general
After more than ten years of development in China's DR industry, technology, products, clinical applications, etc. have undergone tremendous changes. At present, dynamic DR technology has become the most advanced technology in the application level of the industry, and has become a new trend of development, even in the DR industry. A strong slogan of "no dynamic, no DR" appears.
With the development of China's economy and the rapid advancement of medical care, the market size of DR has grown rapidly. Companies with core technologies will see huge returns in the fast-growing DR market, and the Matthew effect will intensify.
In the face of the future, companies based on the Chinese market will find a way out in “import substitutionâ€; companies based on global market products will stand out in the global industrial upgrading.